Latest Breaking News On - India drug action network - Page 21 : comparemela.com

What we know about India s coronavirus vaccines Sun Online Desk   India s Covaxin, the homegrown government-backed vaccine, has an efficacy rate of 81%, preliminary data from its phase 3 trial shows. India s regulators gave the vaccine an emergency approval in January while the third phase of the trial was still under way, sparking scepticism and questions from experts. Bharat Biotech, the vaccine s manufacturer, said the latest findings were an important milestone in vaccine discovery, for science and our fight against coronavirus . With today s results from our phase 3 clinical trials, we have now reported data on our Covid-19 vaccine from phase 1, 2, and 3 trials involving around 27,000 participants, the firm said.

United statesUnited kingdomBiotech corporationWorld health organizationIndia drug action networkIndia national institute of virologyDr reddy labSerum instituteSerum institute of indiaBaylor college of medicineGamaleya national centreNational instituteAll india drug action networkBaylor collegePune based genovaLatin america